Human guanylate binding proteins potentiate the anti-chlamydia effects of interferon-gamma

Illya Tietzel1, Christelle El-Haibi, Rey A Carabeo

  • 1Department of Natural Sciences, Southern University of New Orleans, New Orleans, LA, USA.

Plos One
|August 5, 2009
PubMed

Insights

Human guanylate binding proteins (hGBPs) 1 and 2 enhance the anti-chlamydial effects of interferon-gamma (IFN-gamma). These hGBPs potentiate IFN-gamma

Area of Science:

  • Immunology
  • Microbiology
  • Cell Biology

Background:

  • Chlamydiae are obligate intracellular bacteria sensitive to interferon-gamma (IFN-gamma).
  • Murine p47 GTPases mediate resistance to chlamydia, but human homologues are unknown, leaving the relevance to human pathogenesis unclear.

Purpose of the Study:

  • To identify and characterize human IFN-gamma-inducible proteins that influence chlamydia infection.
  • To investigate the role of human guanylate binding proteins (hGBPs) 1 and 2 in potentiating IFN-gamma's anti-chlamydial activity.

Main Methods:

  • Localization studies of hGBP1 and hGBP2 within infected cells.
  • Assessment of anti-chlamydial activity of hGBPs alone and in combination with IFN-gamma.
  • Analysis of chlamydia growth upon depletion of hGBP1 and hGBP2 in IFN-gamma-treated cells.
  • Investigation of the effect of hGBP overexpression on chlamydia strains with a specific cytotoxin gene.

Main Results:

  • hGBP1 and hGBP2 localize to the chlamydial inclusion membrane and require their GTPase domain for function.
  • hGBP1 and hGBP2 exhibit mild but significant anti-chlamydial effects alone, which are potentiated by sub-inhibitory IFN-gamma concentrations.
  • Depletion of hGBP1 and hGBP2 reduces IFN-gamma's anti-chlamydial efficacy, leading to increased chlamydia inclusion size.
  • Chlamydia strains expressing a full-length cytotoxin gene are unaffected by hGBP overexpression.

Conclusions:

  • Human guanylate binding proteins (hGBPs) 1 and 2 are key mediators that potentiate the anti-chlamydial effects of IFN-gamma.
  • hGBPs may represent targets of the chlamydial cytotoxin, which confers resistance to IFN-gamma-mediated inhibition.

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Antibody Actions01:26

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
Antibody Structure01:10

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...